| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Apr―29 |
Enterobacter roggenkampii producing KPC-3 collected from a hospital sink drain in Portugal during the COVID-19 pandemic |
Gabriel Mendes, Maria Leonor Santos, João F. Ramalho, Aida Duarte, Adriana Pedrosa, Ana Cristina Silva, Lucía Méndez, Cátia Caneiras |
| 2 |
[GO] |
2025―Apr―26 |
Impact of COVID-19 on epidemiology and mortality risk factors in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections in a tertiary care hospital in Thailand |
Darunee Chotiprasitsakul, Korchart Ao-udomsuk, Pitak Santinirand |
| 3 |
[GO] |
2025―Jan―14 |
Drug-resistant tuberculosis is an important challenge in long COVID patients |
Masoud Mohammadi, Seyed Hassan Faghihi |
| 4 |
[GO] |
2024―Dez―27 |
Potential drug interaction after withdrawal of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 infection |
Yun Han, Yonglan Gou, Jieqiong Liu, Lingyan Yu, Yuhua Zhao, Zhenwei Yu |
| 5 |
[GO] |
2024―Dez―26 |
EFFICACY OF HMG-CoA REDUCTASE INHIBITORS IN COVID-19 PATIENTS MORTALITY RATE: A META-ANALYSES OF RANDOMIZED CONTROL TRIALS |
Mohammadreza Shafiei, Mohammadamin Keykhah |
| 6 |
[GO] |
2024―Dez―26 |
Evaluation of the impact of the COVID-19 pandemic on treatment response of newly diagnosed people living with HIV: Turkey experience |
Çiğdem ATAMAN HATİPOĞLU, Halis Akalın, Serhat Ünal, Meliha Çağla Sönmezer, Volkan Korten, Buket Ertürk Şengel, Yeşim Taşova, Ferit Kuşçu, Deniz Gökengin, Nazlıhan Yalçın Ege, Selda Sayın Kutlu, Firuze Soyak, Figen Kaptan Aydoğmuş, Beyza Erol, Şua Sümer, Nazlım Aktuğ Demir, Gönül Çiçek Şentürk, Semanur Kuzi, Uğur Emre Gümüş, Esra Kaya Kılıç, Günay Tuncer Ertem, Sami Kınıklı, Sabri Atalay, Gürsel Ersan, Adalet Altunsoy, Halime Araz, Taner Yıldırmak, Rıdvan Dumlu, İlkay Karaoğlan, Ayşe Özlem Mete, Asuman İnan, Serhat Birengel, Ezgi Gülten, Zehra Karacaer, Dilara İnan, Samet Acar, Emel Yilmaz, Pınar Ergen, Özlem Aydin, Şerife Barçın Öztürk, Petek Şarlak Konya, Aysel Kocagül Çelikbaş, Yüksel Karadağ, Mustafa Kemal Çelen, Çiğdem Mermutluoğlu |
| 7 |
[GO] |
2024―Dez―26 |
Changes in epidemiology of respiratory viruses after COVID-19 pandemic in Daegu City and Gyeongsangbuk-do Province, Korea |
Ji Jung Kim, Hyeok Gyu Kwon, Hee Ju Lim, Sang Bong Han |
| 8 |
[GO] |
2024―Dez―26 |
Multidrug-resistant Organisms Among Patients in COVID-19 Wards Compared to Non-COVID-19 Wards in Indonesian Hospitals |
Shod A. Zulkarnain, Radhitya Abdullah, Ardellia G. Pradnyadevati, Muhammad FR Roesianto, Oktavia K. Putri, Raden BR Padmosudiro, Ryan M. Ramadhan, Susanthy Djajalaksana, Dewi Indiastari, Wiwi Jaya, Arie Z. Fathoni, Irene Ratridewi, Sofiana A. Sahara, Etty F. Ruliatna, Anne Voor in ’t holt, Juliette A. Severin, Nurima DP Hastuti, Sanarto Santoso, Dewi Santosaningsih |
| 9 |
[GO] |
2024―Dez―26 |
The influence of COVID-19 on the incidence and antimicrobial resistance of multi-drug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii in a tertiary care hospital in Belgrade (Serbia) |
Predrag Savic, Milos Gostimirovic, Teodora Vitorovic, Jovana Rajkovic, Ana Bukarica, Ljiljana Gojkovic-Bukarica |
| 10 |
[GO] |
2024―Dez―26 |
The influence of COVID-19 on the antibiotic consumption in a tertiary care hospital in Belgrade (Serbia) |
Milos Gostimirovic, Predrag Savic, Teodora Vitorovic, Jovana Rajkovic, Ana Bukarica, Ljiljana Gojkovic Bukarica |
| 11 |
[GO] |
2024―Dez―26 |
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers of COVID-19 irrespective of patients immunosuppression status: a case-control retrospective single-center study |
Amalia Papanikolopoulou, Eftychia Eirini Maria Gourdoupari, Polyxeni Alexiou, Charalampos Charalampous, Vasiliki Rapti, Maria Effrosyni Livanou, Eleni Kakalou, Vissaria Sakka, Konstantinos N Syrigos, Garyfallia Poulakou |
| 12 |
[GO] |
2024―Dez―26 |
Factors associated with the functional health and well-being of Singapore residents living with the covid-19 endemic |
Zhilian Huang, Kangwei Zeng, Hwee Pin Phua, Chia Siong Wong, Mark I-Cheng Chen |
| 13 |
[GO] |
2024―Dez―26 |
Aggravating factors and post COVID-19 conditions in COVID-19 patients complicated with autoimmune rheumatic diseases |
Yoshihiko Ikeno, Fumiya Fukushima, Azusa Kikuchi, Ryouta Koike, Masafumi Arima, Kazuhiro Kurasawa, Kei Ikeda |
| 14 |
[GO] |
2024―Dez―26 |
Insights from One of the Largest COVID-19 Cohorts: A Detailed Analysis of Risk Factors, Mortality Predictors, and Vaccine Efficacy in Istanbul |
Şiran Keske, Selin Kolsuz, Anı Akpınar, Mahir Kapmaz, Süda Tekin, Bahar Kaçmaz, Yeşim Beşli, Pelin Irkören, Evren Şentürk, Nahit Çakar, Levent Tabak, Veli Oğuzalp Bakır, Mehmet Gönen, Önder Ergönül |
| 15 |
[GO] |
2024―Dez―26 |
Impact of Pre-Existing Comorbidities and Multimorbidities, Demography and Viral Variants on Post-Acute Sequelae of COVID-19 (‘Long COVID’) in Dutch Primary Care: A Retrospective Cohort Study |
Matthijs S Berends, Maarten Homburg, Thijmen Kupers, Eline N Meijer, Isabelle Bos, Robert Verheij, Jeroen Kuiper, Marjolein Berger, Lilian Peters |
| 16 |
[GO] |
2024―Dez―26 |
Prolonged acute inflammatory responses of colonic epithelial cells to SARS-CoV-2 spike protein: implications for gastrointestinal manifestations in COVID-19 |
Aysegul Yilmaz, Sevilay Tura, Seyhan Turk, Can Türk |
| 17 |
[GO] |
2024―Dez―26 |
Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study |
Amalia Papanikolopoulou, Eftychia Eirini Maria Gourdoupari, Charalampos Charalampous, Polyxeni Alexiou, Vasiliki Rapti, Maria Effrosyni Livanou, Maria Kopelia, Vissaria Sakka, Konstantinos N Syrigos, Garyfallia Poulakou |
| 18 |
[GO] |
2024―Dez―26 |
Possible cross protection between influenza and COVID-19: evidence from a pilot review of national surveillance data |
Muhammad Aqmal Bin Mohamad Haris, Smeetha Nair, Jillian Shu En Khoo, Paul Anantharajah Tambyah |
| 19 |
[GO] |
2024―Dez―26 |
Evaluation of The Anti-Viral Response Against SARS-CoV-2 Omicron Variant Appeared In The First Half of 2024 in Healthcare Workers Using In Vitro Cell Culture Model |
Arzuhan Buyuker, Aynur Karadenizli, Emel Azak, Rana Topal |
| 20 |
[GO] |
2024―Dez―26 |
SARS-CoV-2 Still on the Stage: The Need to Pursue an Integrated Respiratory Virus Surveillance |
Mine Durusu Tanriover, Ayşe Tülay Bağcı Bosi, Lale Ozisik, Fırat Şırvan, Tuğçenur Müderrisoğlu, Oğuz Abdullah Uyaroğlu, Ergin Çiftçi, Halil Özdemir, Belkıs Hatice Inceli, Nilay Penezoglu, Rahmet Güner, Bircan Kayaaslan, Keziban Semiz, Kerem Sarcak, Aslınur Özkaya Parlakay, Belgin Gülhan, Şebnem Erdinç, Metin Özsoy, Ahmet Görkem Er, Serhat Ünal |
| 21 |
[GO] |
2024―Nov―26 |
Amikacin, in combination with cations, prevents growth of a carbapenem-resistant/multidrug-resistant Klebsiella pneumoniae strain isolated from a patient with COVID-19 |
Angel J. Magaña, David Ngo, Diego Faccone, Sonia Gomez, Alejandra Corso, Fernando Pasteran, María Soledad Ramirez, Marcelo E. Tolmasky |
| 22 |
[GO] |
2024―Mai―23 |
A Scoping Review of Bacterial Resistance Among Inpatients Amidst the COVID-19 Pandemic |
Noora Reffat, Rebecca J Schwei, Meggie Griffin, Aurora Pop-Vicas, Lucas T Schulz, Michael S Pulia |
| 23 |
[GO] |
2024―Mai―07 |
Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: A retrospective study |
Yichuan Gan, Guowen Zhang, Hengbiao Sun, Xiaoming Lyu |
| 24 |
[GO] |
2024―Mrz―27 |
When it rains it pours: an increased prevalence of intestinal carriage of vancomycin-resistant Enterococcus faecium related to higher use of oral vancomycin in a tertiary care Hungarian clinical center during the years of the COVID-19 pandemic |
László Orosz |
| 25 |
[GO] |
2024―Mrz―07 |
Changes in antimicrobial resistance of Escherichia coli isolated from community associated urinary tract infection before and during the COVID-19 pandemic in India |
Shwetha Venugopal, Sneha Chunchanur, Rajashree Panigrahy, Vibhor Tak, Manish Yadav, Akanksha Chauhan, Himabindhu KS, Jayapriya R, Swati Pundir, Satyendra Bhatt, Birasen Behera, Sumanth M, Ambica R, Susmita Chaudhuri, Sarita Mohapatra |
| 26 |
[GO] |
2024―Jan―26 |
Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae reveals a prolonged outbreak of extensively drug-resistant ST147 NDM-1 during the COVID-19 pandemic in the Apulia region (Southern Italy) |
Daniela Loconsole, Anna Sallustio, Davide Sacco, Marilina Santantonio, Daniele Casulli, Domenico Gatti, Marisa Accogli, Antonio Parisi, Riccardo Zagaria, Vito Colella, Francesca Centrone, Maria Chironna |
| 27 |
[GO] |
2024―Jan―03 |
An Evaluation of the Five Rights Antibiotic Safety Before and During COVID-19 at an NHS Foundation Trust in the United Kingdom |
Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour |
| 28 |
[GO] |
2023―Aug―22 |
Co-infection in COVID-19 patients performed microbiology detection: discovering multi-drug resistant microorganisms increased during the COVID-19 pandemic in Shanghai, China |
Xin Jin, Liyan Zeng, Lijun Zhang, Zhaoqin Zhu |
| 29 |
[GO] |
2023―Apr―13 |
Corrigendum to “Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic” [Journal of Global Antimicrobial Resistance 33 (2023) 89-96] |
Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, Yanyi Weng, Angela Chow |
| 30 |
[GO] |
2023―Mrz―10 |
Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic |
Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, Yanyi Weng, Angela Chow |
| 31 |
[GO] |
2022―Dez―23 |
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial |
Florian Kurth, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Gianluca Barbone, Marius A. Eckart, Martin Kluge, Tobias Puengel, Münevver Demir, Robert Röhle, Theresa Keller, Christoph Ruwwe-Glösenkamp, Martin Witzenrath, Norbert Suttorp, Christof von Kalle, Leif E. Sander, Christoph Jochum, Frank Tacke |
| 32 |
[GO] |
2022―Dez―19 |
61: SECONDARY INFECTION DURING THE THIRDWAVE OF COVID-19 IN A HOSPITAL IN KATHMANDU |
S.K. Mishra Baishnab |
| 33 |
[GO] |
2022―Dez―19 |
WS1.3: DETERMINANTS OF ANTIBIOTIC EXPECTATION AND RECEIPT AMONG PATIENTS PRESENTING TO EMERGENCY DEPARTMENTS WITH UPPER RESPIRATORY TRACT INFECTION DURING THE COVID-19 PANDEMIC |
Zhilian Huang, Angela Chow |
| 34 |
[GO] |
2022―Dez―19 |
WS1.2: USE OF ANTIBIOTICS IN COVID-19 PATIENTS AND ANTIBACTERIAL RESISTANCE PATTERN- A COUNTRYWIDE PICTURE |
Shrebash Paul, Tabiha Binte Hannan, T.M. Al-Amin, Md. Mohiuddin Khan, Binayak Bhattacharjee, Md. Zainal Abedin, Pritish Tarafder, Md. Abul Kalam Azad, Shohael Mahmud Arafat, Md. Rafiqul Alam, Md. Mujibur Rahman, Fazle Rabbi Chowdhury |
| 35 |
[GO] |
2022―Dez―19 |
63: A MICROBIOLOGICAL RETROSPECTIVE REVIEW OF BLOOD STREAM INFECTIONS IN COVID-19 PATIENTS FROM A TERTIARY CARE CENTER IN LEBANON |
S. Nahhal, N. Zahreddine, J. Tannous, N. Haddad, J. Zakhour, A. Shmoury, T. Sawma, N. Rizk, S.S Kanj |
| 36 |
[GO] |
2022―Dez―19 |
64: BACTERIAL RESPIRATORY INFECTIONS IN PATIENTS WITH COVID-19: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTER IN LEBANON |
A. Shmoury, T. Sawma, S.F. Haddad, N. Zahreddine, J. Tannous, J. Zakhour, N. Rizk, S.S Kanj |
| 37 |
[GO] |
2022―Dez―19 |
54: THE IMPACT OF THE CORONAVIRUS DISEASE PANDEMIC ON RESPIRATORY-RELATED INFECTIONS IN JAPAN |
D. Kitagawa, T. Kitano, M. Furumori, S. Suzuki, Y. Shintani, A. Nishiyama, T. Kasamatsu, N. Shiraishi, Y. Suzuki, A. Nakano, R. Nakano, H. Yano, K. Maeda, S. Yoshida, F. Nakamura |
| 38 |
[GO] |
2022―Dez―19 |
58: SARS-COV-2 ANTIBODY CHARACTERISTICS OF SALIVA FROM VACCINATED INDIVIDUALS |
K. Ota, F. Mitsumoto-Kaseida, K. Sakamoto, K. Kosai, H. Hasegawa, K. Yamamoto, K. Izumikawa, H. Mukae, S. Kohno, K. Yanagihara |
| 39 |
[GO] |
2022―Dez―19 |
69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
M.V.R. Macatangay, J.A. Buensalido |
| 40 |
[GO] |
2022―Dez―01 |
Effect of Farnesyltransferase Inhibitors on SARS-CoV-2 |
Lea Weber, Lena Mautner, Mona Hoyos, Anja Ehrhardt, Armin Baiker, Hagen Sjard Bachmann |
| 41 |
[GO] |
2022―Nov―08 |
Replacement of KPC-producing pandemic lineages and dissemination of plasmids associated to antimicrobial resistance determinants during inpatient´s hospitalization |
Verónica E. Álvarez, Natalia García Allende, Mariana G. Massó, María Piekar, Josefina Campos, Barbara Fox, Anahí S. Gambino, Liliana Fernández-Canigia, María P. Quiroga, Daniela Centrón |
| 42 |
[GO] |
2022―Okt―05 |
In vitro activity of ceftazidime/avibactam against carbapenem-non-susceptible Klebsiella penumoniae isolates collected during SARS-CoV-2 pandemic: a Southern Italy, multi-center, surveillance study |
Gianfranco La Bella, Teresa Lopizzo, Laura Lupo, Rosa Angarano, Anna Curci, Barbara Manti, Giovanna La Salandra, Adriana Mosca, Rosella De Nittis, Fabio Arena |
| 43 |
[GO] |
2022―Jun―13 |
Overuse of empirical antibiotics in a Covid-19 intensive care unit led to the spread of carbapenem-resistant Gram-negative bacteria in a teaching hospital |
Daniela Dambroso-Altafini, Silvia Maria dos Santos Saalfeld, Monica de Souza Ferreira de Mattos, Hilton Vizzi Martinez, Danielle Rosani Shinohara, Mirian Nicéa Zarpellon, Bruno Buranello Costa, Maria Cristina Bronharo Tognim |
| 44 |
[GO] |
2022―Feb―25 |
Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom |
Venkata R. Emani, Raghunath Reddy, Kartik K. Goswami, Abirath S. Nakka, Shaila R. Emani, Nikhila K. Reddy, Kailash R. Maddula, Dheeraj Nandanoor, Sanjeev Goswami |
| 45 |
[GO] |
2022―Jan―14 |
In vitro evaluation of virucidal activity of disodium citrate perhydrate (2SCP) disinfectant against SARS-CoV-2 virus |
Géraldine Dessilly, Anne-thérèse Pâques, Anne-thérèse Vandenbroucke, Pierre Hazée, Alain Gaume, Katia Gindro, Sylvain Schnée, Frédéric Lakaye, Benoît Kabamba-Mukadi |
| 46 |
[GO] |
2021―Nov―12 |
Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy |
Briony Adams, Alec Beaney |
| 47 |
[GO] |
2021―Nov―04 |
COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review |
Nobuhiro Asai, Hiroshige Mikamo |
| 48 |
[GO] |
2021―Okt―28 |
Repatriation of patient with COVID-19 contributed to the importation of an emerging carbapenemase producer |
Aline I. Moser, Edgar I. Campos-Madueno, Parham Sendi, Vincent Perreten, Peter M. Keller, Alban Ramette, Andrea Endimiani |
| 49 |
[GO] |
2021―Sep―22 |
Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report |
Luca Borghesi, Valentina Viaggi, Marco Franzetti, Matteo Montoli, Carola Mauri, Giovanni Moioli, Mauro Roberto Benvenuti, Stefania Piconi, Francesco Luzzaro |
| 50 |
[GO] |
2021―Sep―04 |
Shortage in Appropriate Diagnostics of Antimicrobial Resistance in Lebanese Clinical Settings: A Crisis Amplified by COVID-19 and Economic Collapse |
Marwan Osman, Dalal Kasir, Issmat I. Kassem, Monzer Hamze |
| 51 |
[GO] |
2021―Jul―15 |
Loss of Function Mutations in the IFNAR2 in COVID-19 Severe Infection Susceptibility |
Sandra P. Smieszek, Mihael H. Polymeropoulos |
| 52 |
[GO] |
2021―Jul―07 |
Vaccine or Monoclonal therapy: which is winning weapon against COVID-19? |
Lorenzo Lo Muzio, Maria Eleonora Bizzoca |
| 53 |
[GO] |
2021―Jun―09 |
What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web-survey helps us understand where the doubts lie |
Marta Colaneri, Pietro Valsecchi, Marco Vecchia, Alessandro Di Filippo, Valentina Zuccaro, Elena Seminari, Paolo Sacchi, Laura Maiocchi, Massimiliano Fabbiani, Alessandra Ricciardi, Alba Muzzi, Raffaele Bruno |
| 54 |
[GO] |
2021―Mai―27 |
Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses |
Jeswin Joseph, T. Karthika, V.R. Akshay Das, V. Stalin Raj |
| 55 |
[GO] |
2021―Mrz―01 |
AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic |
Jesús Rodríguez-Baño, Gian Maria Rossolini, Constance Schultsz, Evelina Tacconelli, Srinivas Murthy, Norio Ohmagari, Alison Holmes, Till Bachmann, Herman Goossens, Rafael Canton, Adam P. Roberts, Birgitta Henriques-Normark, Cornelius J. Clancy, Benedikt Huttner, Patriq Fagerstedt, Shawon Lahiri, Charu Kaushic, Steven J. Hoffman, Margo Warren, Ghada Zoubiane, Sabiha Essack, Ramanan Laxminarayan, Laura Plant |
| 56 |
[GO] |
2021―Mrz―01 |
Genomic Data Reveals the Emergence of IncQ1 Small Plasmid Carrying blaKPC-2 in Escherichia coli of the Pandemic Sequence Type 648 |
Bruna Fuga, Louise Cerdeira, Quézia Moura, Herrison Fontana, Danny Fuentes-Castillo, Albalúcia C. Carvalho, Nilton Lincopan |
| 57 |
[GO] |
2021―Jan―18 |
Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2 |
Alasdair MacGowan, Fergus Hamilton, Mark Bayliss, Liam Read, Marie Attwood, Alan Noel, Sally Grier, Anna Morley, David Arnold, Nicholas Maskell |
| 58 |
[GO] |
2020―Dez―29 |
Antiviral activity of interferon-based combination therapy in critically ill patients with Covid-19: preliminary observations |
Paolo Gaibani, Tommaso Tonetti, Michele Bartoletti, Maria Carla Re, PierLuigi Viale, V. Marco Ranieri |
| 59 |
[GO] |
2020―Dez―25 |
Treatment of a case with COVID-19 administering intravenous immunoglobulin |
Mustafa Çolak, Serdar Kalemci, Aydın Sarıhan |
| 60 |
[GO] |
2020―Dez―08 |
A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19) |
Sock Hoon Tan, Tat Ming Ng, Hui Lin Tay, Min Yi Yap, Shi Thong Heng, Audrey Yong Xin Loo, Christine B. Teng, Tau Hong Lee |
| 61 |
[GO] |
2020―Dez―08 |
Remdesivir for the treatment of coronavirus COVID-19: a meta-analysis of randomised controlled trials |
Yuki Enoki, Yuki Igarashi, Yuki Watabe, Kyoka Honma, Yuto Suzuki, Yukitaka Hayashi, Kana Hiraoka, Kazuaki Taguchi, Kazuaki Matsumoto |
| 62 |
[GO] |
2020―Nov―23 |
Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak |
Daniel O. Griffin, Alexandra Jensen, Mushmoom Khan, Jessica Chin, Kelly Chin, Jennifer Saad, Ryan Parnell, Christopher Awwad, Darshan Patel |
| 63 |
[GO] |
2020―Nov―23 |
Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball |
G. Montrucchio, S. Corcione, G. Sales, A. Curtoni, F.G. De Rosa, L. Brazzi |
| 64 |
[GO] |
2020―Okt―29 |
INCIDENCE OF BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN COVID-19 PATIENTS IN INTENSIVE CARE: AN ALARMING “COLLATERAL EFFECT” |
Maria Adriana Cataldo, Nardi Tetaj, Marina Selleri, Luisa Marchioni, Alessandro Capone, Emanuela Caraffa, Antonino Di Caro, Nicola Petrosillo |
| 65 |
[GO] |
2020―Okt―17 |
Ototoxicity prevention during the SARS-CoV-2 (Covid-19) emergency |
Andrea Ciorba, Piotr Henryk Skarżyński, Stefano Pelucchi, Stavros Hatzopoulos |
| 66 |
[GO] |
2020―Okt―13 |
A Possible Application of High Dose Vitamin C in the Prevention and Therapy for Coronavirus Infections |
Ba X. Hoang, D. Graeme Shaw, William Fang, Bo Han |
| 67 |
[GO] |
2020―Aug―20 |
A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island |
Arthur Dubernet, Kevin Larsen, Laurie Masse, Jérôme Allyn, Emilie Foch, Lea Bruneau, Adrien Maillot, Marie Lagrange-Xelot, Vincent Thomas, Marie-Christine Jaffar-Bandjee, Loraine Gauzere, Loic Raffray, Karine Borsu, Servane Dibernardo, Stéphane Renaud, Michel André, Diane Moreau, Julien Jabot, Nathalie Coolen-Allou, Nicolas Allou |
| 68 |
[GO] |
2020―Aug―15 |
Neutrophil-to-lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients |
Shaghayegh Haghjooy Javanmard, Golnaz Vaseghi, Amir Reza Manteghi Nezhad, Maryam Nasirian |
| 69 |
[GO] |
2020―Aug―15 |
Usefulness of brochoalveolar lavage in suspect covid-19 repeatedly negative swab test and interstitial lung disease |
Jacopo Vannucci, Franco Ruberto, Daniele Diso, Gioacchino Galardo, Claudio M. Mastroianni, Giammarco Raponi, Massimiliano Bassi, Giancarlo Ceccarelli, Massimo Mancone, Guido Antonelli, Federico Venuta, Francesco Pugliese |
| 70 |
[GO] |
2020―Aug―08 |
Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-COV-2 infection? |
Sudhir Mehta, Sudhir Bhandari, Shaurya Mehta |
| 71 |
[GO] |
2020―Aug―05 |
Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study |
Markos Kalligeros, Fadi Shehadeh, Eleftheria Atalla, Evangelia K. Mylona, Su Aung, Aakriti Pandita, Jerry Larkin, Martha Sanchez, Francine Touzard-Romo, Amy Brotherton, Rajeev Shah, Cheston B. Cunha, Eleftherios Mylonakis |
| 72 |
[GO] |
2020―Jul―25 |
Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care |
Lesley Heesom, Lucas Rehnberg, Myra Nasim-Mohi, Alexander I.R. Jackson, Michael Celinski, Ahilanadan Dushianthan, Paul Cook, William Rivinberg, Kordo Saeed |
| 73 |
[GO] |
2020―Jul―16 |
Could Bordetella pertussis vaccine protect against coronavirus COVID-19? |
Usama M. Alkholy, Mohamed E Salama, Hagar Mahmoud, Ahmed Taher, Khaled M. Elsayes |
| 74 |
[GO] |
2020―Jul―11 |
Perceived Challenges of COVID-19 Infection Prevention and Control Preparedness: A Multinational Survey |
Ermira Tartari, Joost Hopman, Benedetta Allegranzi, Bin Gao, Andreas Widmer, Vincent Chi-Chung Cheng, Shuk Ching Wong, Kalisvar Marimuthu, Folasade Ogunsola, Andreas Voss |
| 75 |
[GO] |
2020―Jul―02 |
SARS-CoV-2 positivity in rectal swabs implication for possible transmission |
Federica Novazzi, Irene Cassaniti, Antonio Piralla, Antonio Di Sabatino, Raffaele Bruno, Fausto Baldanti |
| 76 |
[GO] |
2020―Jul―01 |
Azithromycin and SARS-CoV-2 infection: where we are now and where we are going |
Luis Gabriel Parra-Lara, Juan José Martínez-Arboleda, Fernando Rosso |
| 77 |
[GO] |
2020―Jun―12 |
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic |
Anuradha Chowdhary, Amit Sharma |
| 78 |
[GO] |
2020―Mai―29 |
Vitamin D deficiency and COVID-19 pandemic |
Patrick Zemb, Peter Bergman, Carlos A. Camargo, Etienne Cavalier, Catherine Cormier, Marie Courbebaisse, Bruce Hollis, Salvatore Minisola, Stefan Pilz, Pawel Pludowski, François Schmitt, Mihnea Zdrenghea, Jean-Claude Souberbielle |
| 79 |
[GO] |
2020―Apr―27 |
Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19 |
Farzaneh Dastan, Ali Saffaei, Seyed Mehdi Mortazavi, Hamidreza Jamaati, Nadia Adnani, Sasan Samiee Roudi, Arda Kiani, Atefeh Abedini, Seyed MohammadReza Hashemian |
| 80 |
[GO] |
2020―Mrz―07 |
2019-novel coronavirus outbreak: A new challenge |
Tommaso Lupia, Silvia Scabini, Simone Mornese Pinna, Giovanni Di Perri, Francesco Giuseppe De Rosa, Silvia Corcione |
|
